Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers.

SA Harrison, S Calanna, K Cusi, M Linder, T Okanoue, V Ratziu, A Sanyal, AS Sejling, PN Newsome

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Contemporary Clinical Trials
DOIs	https://doi.org/10.1016/j.cct.2020.106174
Publication status	Published - 1 Oct 2020

Access to Document

@article{4dc767e9b2634b13adc1190a5476e11c,

title = "Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers.",

author = "SA Harrison and S Calanna and K Cusi and M Linder and T Okanoue and V Ratziu and A Sanyal and AS Sejling and PN Newsome",

year = "2020",

month = oct,

day = "1",

doi = "10.1016/j.cct.2020.106174",

language = "English",

journal = "Contemporary Clinical Trials",

issn = "1551-7144",

publisher = "Elsevier",

}

TY - JOUR

T1 - Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers.

AU - Harrison, SA

AU - Calanna, S

AU - Cusi, K

AU - Linder, M

AU - Okanoue, T

AU - Ratziu, V

AU - Sanyal, A

AU - Sejling, AS

AU - Newsome, PN

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://europepmc.org/abstract/med/33039693

U2 - 10.1016/j.cct.2020.106174

DO - 10.1016/j.cct.2020.106174

M3 - Article

C2 - 33039693

SN - 1551-7144

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

ER -